ICOS logo

Intercos S.p.A. Stock Price

BIT:ICOS Community·€1.2b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 8 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

ICOS Share Price Performance

€12.78
0.40 (3.23%)
​
€16.24
Fair Value
€12.78
0.40 (3.23%)
21.3% undervalued intrinsic discount
€16.24
Fair Value
Price €12.78
AnalystConsensusTarget €16.24
AnalystLowTarget €13.00
AnalystHighTarget €20.00

ICOS Community Narratives

Fair Value
·
Fair Value €16.24 21.3% undervalued intrinsic discount

Expanding Asia-Pacific Facilities And Advanced R&D Will Create Future Value

1users have liked this narrative
0users have commented on this narrative
4users have followed this narrative
Fair Value
·
Fair Value €13 1.7% undervalued intrinsic discount

Tariff And Capacity Pressures Will Challenge Beauty Outsourcing While Long-Term Margins Slowly Improve

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
Fair Value
·
Fair Value €20 36.1% undervalued intrinsic discount

Rebalanced Client Mix And Margin Expansion Will Support Stronger Long Term Earnings Potential

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
ICOS logo
Intercos
21.3% undervalued intrinsic discount

Expanding Asia-Pacific Facilities And Advanced R&D Will Create Future Value

View narrative
Updated 18 Jun
Read Narrative
ICOS logo
Intercos
36.1% undervalued intrinsic discount

Rebalanced Client Mix And Margin Expansion Will Support Stronger Long Term Earnings Potential

View narrative
Published 12 Jan
Read Narrative
ICOS logo
Intercos
1.7% undervalued intrinsic discount

Tariff And Capacity Pressures Will Challenge Beauty Outsourcing While Long-Term Margins Slowly Improve

View narrative
Published 17 Dec 2025
Read Narrative

Trending Discussion

No trending discussion available.

Updated Narratives

ICOS logo

ICOS: Confirmed 2026 Guidance Will Support Further Share Price Upside

Fair Value: €16.24 21.3% undervalued intrinsic discount
4 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
ICOS logo

Rebalanced Client Mix And Margin Expansion Will Support Stronger Long Term Earnings Potential

Fair Value: €20 36.1% undervalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
ICOS logo

Tariff And Capacity Pressures Will Challenge Beauty Outsourcing While Long-Term Margins Slowly Improve

Fair Value: €13 1.7% undervalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Flawless balance sheet with solid track record.

0 Risks
3 Rewards
View Full Analysis

Intercos S.p.A. Key Details

€1.0b

Revenue

€816.3m

Cost of Revenue

€218.6m

Gross Profit

€161.5m

Other Expenses

€57.1m

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
Nov 05, 2026
0.61
21.12%
5.52%
45.7%
View Full Analysis

About ICOS

Founded
1972
Employees
4230
CEO
Renato Semerari
WebsiteView website
www.intercos.com

Intercos S.p.A., together with its subsidiaries, creates, produces, and markets cosmetics and skin care products worldwide. The company operates through Make Up, Skincare, and Hair & Body segments. It offers powders, foundation, lipsticks, mascara, nail polish, delivery systems, creams, serums, dermo cosmetic lotions, and hair care products. The company sells its products to multinational brands, emerging brands, and retailers. Intercos S.p.A. was founded in 1972 and is headquartered in Agrate Brianza, Italy.

Recent ICOS News & Updates

Analysis Article • Aug 07

Intercos S.p.A. (BIT:ICOS) Just Reported Half-Year Earnings: Have Analysts Changed Their Mind On The Stock?

Investors in Intercos S.p.A. ( BIT:ICOS ) had a good week, as its shares rose 2.2% to close at €14.00 following the...
Narrative Update • Jun 18

ICOS: Confirmed 2026 Guidance Will Support Further Share Price Upside

Analysts have kept their fair value estimate for Intercos steady at about €16.24 per share, with only small tweaks to assumptions such as the discount rate, revenue growth, profit margin and future P/E used to support the price target. What's in the News for Intercos Intercos reaffirmed its earnings guidance for fiscal year 2026, confirming existing expectations for the period.

Recent updates

No updates

Intercos S.p.A. Competitors

PHN logo

Pharmanutra

Symbol: BIT:PHN
Market cap: €701.9m
View more competitors